Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-048820

Chief Executive Officer sold 4,400 shares at an average $14.67 ($64,526)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2017-08-10 Sale −2,200 $14.75 $32,450 448,378 I
Ciechanover Isaac E. Chief Executive Officer 2017-08-11 Sale −2,200 $14.58 $32,076 446,178 I
Open-market sales · 4,400 sh · avg $14.67 · $64,526
Loading xslF345X03/doc4.xml…